Literature DB >> 25438368

Controversies surrounding screening mammography.

Pamela M Otto, Christa B Blecher.   

Abstract

Screening for breast cancer with mammography has been shown in multiple randomized control trials to decrease breast cancer mortality. Despite this, there are ongoing controversies regarding the benefits and risks of mammographic screening. Different professional groups have published conflicting guidelines regarding when to start screening, how often to screen, and when to stop screening which have added to the confusion. In this article we describe the evidence supporting and challenging the efficacy of mammography and review our real world approach to breast cancer screening.

Entities:  

Mesh：

Year:  2014        PMID： 25438368      PMCID： PMC6172104     

Source DB:  PubMed          Journal:  Mo Med        ISSN： 0026-6620


  22 in total

1.  Is mammographic screening justifiable considering its substantial overdiagnosis rate and minor effect on mortality?

Authors:  Karsten Juhl Jørgensen; John D Keen; Peter C Gøtzsche
Journal:  Radiology       Date:  2011-09       Impact factor: 11.105

2.  A failure analysis of invasive breast cancer: most deaths from disease occur in women not regularly screened.

Authors:  Matthew L Webb; Blake Cady; James S Michaelson; Devon M Bush; Katherina Zabicki Calvillo; Daniel B Kopans; Barbara L Smith
Journal:  Cancer       Date:  2013-09-09       Impact factor: 6.860

3.  Breast Cancer Detection Demonstration Project: five-year summary report.

Authors:  L H Baker
Journal:  CA Cancer J Clin       Date:  1982 Jul-Aug       Impact factor: 508.702

4.  Is screening for breast cancer with mammography justifiable?

Authors:  P C Gøtzsche; O Olsen
Journal:  Lancet       Date:  2000-01-08       Impact factor: 79.321

5.  Beyond randomized controlled trials: organized mammographic screening substantially reduces breast carcinoma mortality.

Authors:  L Tabár; B Vitak; H H Chen; M F Yen; S W Duffy; R A Smith
Journal:  Cancer       Date:  2001-05-01       Impact factor: 6.860

6.  Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement.

Authors: 
Journal:  Ann Intern Med       Date:  2009-11-17       Impact factor: 25.391

7.  Long-term psychosocial consequences of false-positive screening mammography.

Authors:  John Brodersen; Volkert Dirk Siersma
Journal:  Ann Fam Med       Date:  2013 Mar-Apr       Impact factor: 5.166

8.  Reduction in mortality from breast cancer after mass screening with mammography. Randomised trial from the Breast Cancer Screening Working Group of the Swedish National Board of Health and Welfare.

Authors:  L Tabár; C J Fagerberg; A Gad; L Baldetorp; L H Holmberg; O Gröntoft; U Ljungquist; B Lundström; J C Månson; G Eklund
Journal:  Lancet       Date:  1985-04-13       Impact factor: 79.321

Review 9.  The benefits and harms of breast cancer screening: an independent review.

Authors: 
Journal:  Lancet       Date:  2012-10-30       Impact factor: 79.321

10.  Twenty five year follow-up for breast cancer incidence and mortality of the Canadian National Breast Screening Study: randomised screening trial.

Authors:  Anthony B Miller; Claus Wall; Cornelia J Baines; Ping Sun; Teresa To; Steven A Narod
Journal:  BMJ       Date:  2014-02-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.